Eccrine squamous syringometaplasia associated with sunitinib therapy
- 2 August 2007
- journal article
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 21 (8), 1136-1137
- https://doi.org/10.1111/j.1468-3083.2006.02123.x
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Imatinib-induced eccrine squamous syringometaplasiaJournal of the American Academy of Dermatology, 2006
- Sunitinib in Patients With Metastatic Renal Cell CarcinomaJama-Journal Of The American Medical Association, 2006
- Sunitinib maleateNature Reviews Drug Discovery, 2006
- Safety, Pharmacokinetic, and Antitumor Activity of SU11248, a Novel Oral Multitarget Tyrosine Kinase Inhibitor, in Patients With CancerJournal of Clinical Oncology, 2006
- Cutaneous side-effects of kinase inhibitors and blocking antibodiesThe Lancet Oncology, 2005
- Mucocutaneous reactions to chemotherapyJournal of the American Academy of Dermatology, 1999
- Eccrine squamous syringometaplasiaJournal of Cutaneous Pathology, 1993